Related Experiment Video
Updated: Mar 1, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms
Bo Zheng1,2, Yan-Jing Zhu1,2, Hong-Yang Wang3,4,5
1International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai, 200438, China.
Insights
Sex hormones significantly influence hepatitis B virus (HBV)-induced liver cancer (HCC). Estrogen and androgens impact HBV replication and inflammation, affecting HCC development and progression differently in males and females.
Area of Science:
- Hepatology
- Oncology
- Endocrinology
Background:
- Hepatitis B virus (HBV) infection is a primary cause of hepatocellular carcinoma (HCC), particularly in endemic Asian regions.
- Males exhibit a three times higher incidence of inflammation-driven HCC compared to females.
- Sex hormones are increasingly recognized for their critical role in HBV-induced HCC pathogenesis.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying sex differences in HBV-associated HCC.
- To review the impact of sex hormones on HBV gene transcription, replication, and inflammatory responses.
- To explore potential therapeutic strategies for inflammation-driven HCC.
Main Methods:
- Review of epidemiological data on HBV-induced HCC incidence and sex differences.
- Analysis of molecular pathways involving estrogen and androgen signaling in HBV infection.
- Investigation of sex hormone-mediated epigenetic modifications in HCC development.
Main Results:
- Estrogen/androgen signaling pathways differentially regulate HBV gene transcription and replication.
- Sex hormones modulate HBV RNA transcription and inflammatory cytokine levels, influencing HCC progression.
- Sex hormones contribute to HBV-related HCC through epigenetic alterations.
Conclusions:
- Sex hormones play a pivotal role in the sex-specific development and progression of HBV-induced HCC.
- Understanding these molecular mechanisms is crucial for developing targeted therapies.
- Further research is needed to fully elucidate the complex interplay between sex hormones, HBV, and HCC.
Abstract:
On the global scale, hepatitis B virus (HBV) infection is the main cause of hepatocellular carcinoma (HCC) especially in regions of Asia where HBV infection is endemic. Epidemiological studies show that the incidence of inflammation-driven HCC in males is three times as high as in females. Recent studies suggest that sex hormones have a crucial role in the pathogenesis and development of HBV-induced HCC. We found that the estrogen/androgen signaling pathway is associated with decreased/increased transcription and replication of HBV genes and can promote the development of HBV infections by up/downregulating HBV RNA transcription and inflammatory cytokines levels, which in turn slow down the progression of HBV-induced HCC. Additionally, sex hormones can also affect HBV-related HCC by inducing epigenetic changes. The evidence that both morphology and function of the human liver are affected by sex hormones was found over 60 years ago. However, the underlying molecular mechanism largely remains to be elucidated. This review focuses mainly on the molecular mechanisms behind the sex difference in HCC associated with HBV and other factors. In addition, several potential treatment and therapeutic strategies for inflammation-driven HCC will be introduced in this review.
More Related Videos
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Cancer Prevention
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...